Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-18-003119
Filing Date
2018-03-13
Accepted
2018-03-12 17:57:00
Documents
7
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A cerecor-pre14ax2018.htm PRE 14A 834735
2 cerecor2018pre14a1014_image1.jpg GRAPHIC 14578
3 mariamsignature01.jpg GRAPHIC 21578
4 pxb20385001.jpg GRAPHIC 75122
5 pxf20385a01001.jpg GRAPHIC 191916
6 pxi20385001.jpg GRAPHIC 225301
7 pxn20385001.jpg GRAPHIC 206968
  Complete submission text file 0001628280-18-003119.txt   1844119
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37590 | Film No.: 18684650
SIC: 2834 Pharmaceutical Preparations